The results suggested that HQT has protective effect against hepatic steatosis and inflammation in NAFLD rats by attenuating ER stress, and the potential mechanism is through inhibition of PERK and ATF6 pathways. This evidence concerns the gene ATF6 and metabolic dysfunction-associated steatotic liver disease.